Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 8,496 shares at $21.36 ($181K) on 2024-07-01, disclosed to the SEC on 2024-07-03.
Scheduled sale ($181k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.36 | 4,248 | $91K | 50.0% |
| 2 | $21.36 | 4,248 | $91K | 50.0% |
| Total | $21.36 avg | 8,496 | $181K | 100% |
| Filing → |
| FDMT | SELL | 2026-08-17 | $40K | — | Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |